ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Ajinomoto to expand API production in India

by Rick Mullin
August 21, 2020 | APPEARED IN VOLUME 98, ISSUE 32

 

09832-buscon14-ajinomoto.jpg
Credit: Ajinomoto
Ajinomoto's facility in India

Ajinomoto Bio-Pharma Services has begun construction on an 8,500 m2 small-molecule active pharmaceutical ingredient (API) facility at its site in Visakhapatnam, India. The facility will double reactor capacity at the site to 310 m3 for products that include highly potent APIs and intermediates. The project includes renovation of laboratory space to support R&D expansion. The project should create at least 60 jobs and be complete by mid-2022, according to Ajinomoto.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment